For Industry

Orphan Drug Regulations-Proposed Rule

The Food and Drug Administration (FDA) is proposing to amend the 1992 Orphan Drug Regulations issued to implement the Orphan Drug Act. These amendments are intended to clarify regulatory provisions and make minor improvements to address issues that have arisen since those regulations were issued.

Orphan Drug Regulations-Proposed Rule:
Docket No. FDA-2011-N-0583]
RIN 0910-AG72

The period to provide comments to the Orphan Drug Regulations-Proposed Rule closed on January 17, 2012. Public submission comments to the Orphan Drug Regulations-Proposed Rule may be viewed at by searching the Docket No. FDA-2011-N-0583. The FDA is currently reviewing the comments.

For questions regarding the proposed rule contact:

Ms. Erica K McNeilly

Page Last Updated: 02/17/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English